Genetic Disorder L.P. Kkr Sells 6,000,000 Shares of KKR & Co. Inc. (NYSE:KKR) Stock

KKR & Co. Inc. (NYSE:KKR) major shareholder Genetic Disorder L.P. Kkr sold 6,000,000 shares of the company’s stock in a transaction that occurred on Monday, May 12th. The shares were sold at an average price of $34.20, for a total value of $205,200,000.00. Following the completion of the transaction, the insider now owns 13,260,971 shares in the company, valued at approximately $453,525,208.20. The trade was a 31.15% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Major shareholders that own more than 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

Genetic Disorder L.P. Kkr also recently made the following trade(s):

• On Wednesday, March 5th, Genetic Disorder L.P. Kkr sold 6,000,000 shares of KKR & Co. Inc. stock. The shares were sold at an average price of $32.96, for a total value of $197,760,000.00.

KKR & Co. Inc. Trading Down 2.8%

Shares of KKR stock opened at $125.42 on Friday. The stock has a market capitalization of $111.40 billion, a price-to-earnings ratio of 37.66, a PEG ratio of 1.00 and a beta of 1.91. KKR & Co. Inc. has a 1 year low of $86.15 and a 1 year high of $170.40. The company’s fifty day simple moving average is $111.94 and its two-hundred day simple moving average is $135.77. The company has a debt-to-equity ratio of 0.82, a current ratio of 0.07 and a quick ratio of 0.07.

KKR & Co. Inc. (NYSE:KKR) last released its quarterly earnings results on Thursday, May 1st. The asset manager reported $1.15 earnings per share for the quarter, topping the consensus estimate of $1.13 by $0.02. The firm had revenue of $1.77 billion for the quarter, compared to analysts’ expectations of $1.71 billion. KKR & Co. Inc. had a net margin of 14.31% and a return on equity of 6.20%. The business’s quarterly revenue was down 67.8% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.97 earnings per share. As a group, analysts anticipate that KKR & Co. Inc. will post 5.19 earnings per share for the current year.

KKR & Co. Inc. Increases Dividend

The company also recently declared a dividend, which will be paid on Tuesday, May 27th. Stockholders of record on Tuesday, May 13th will be issued a $0.185 dividend. The ex-dividend date of this dividend is Monday, May 12th. This represents a dividend yield of 0.64%. This is a boost from KKR & Co. Inc.’s previous dividend of $0.17. KKR & Co. Inc.’s dividend payout ratio is presently 31.22%.

Wall Street Analysts Forecast Growth

Several research firms recently commented on KKR. Bank of America dropped their price objective on KKR & Co. Inc. from $214.00 to $194.00 and set a “buy” rating on the stock in a research note on Friday, April 4th. Hsbc Global Res upgraded KKR & Co. Inc. from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, April 15th. Barclays upped their price objective on KKR & Co. Inc. from $129.00 to $141.00 and gave the company an “overweight” rating in a research note on Friday, May 2nd. Wells Fargo & Company upped their price objective on KKR & Co. Inc. from $120.00 to $136.00 and gave the company an “overweight” rating in a research note on Friday, May 2nd. Finally, Keefe, Bruyette & Woods upped their price objective on KKR & Co. Inc. from $129.00 to $131.00 and gave the company an “outperform” rating in a research note on Friday, May 2nd. One research analyst has rated the stock with a sell rating, fourteen have given a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Buy” and a consensus target price of $149.14.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in KKR. Norges Bank bought a new position in shares of KKR & Co. Inc. in the fourth quarter worth $1,435,314,000. Nuveen LLC bought a new position in shares of KKR & Co. Inc. in the first quarter worth $844,137,000. Jennison Associates LLC increased its holdings in shares of KKR & Co. Inc. by 4,918.6% in the first quarter. Jennison Associates LLC now owns 4,393,841 shares of the asset manager’s stock worth $507,972,000 after purchasing an additional 4,306,290 shares during the period. Nuveen Asset Management LLC increased its holdings in shares of KKR & Co. Inc. by 106.2% in the fourth quarter. Nuveen Asset Management LLC now owns 6,584,370 shares of the asset manager’s stock worth $973,894,000 after purchasing an additional 3,391,581 shares during the period. Finally, Massachusetts Financial Services Co. MA increased its stake in KKR & Co. Inc. by 14.3% in the first quarter. Massachusetts Financial Services Co. MA now owns 19,081,760 shares of the asset manager’s stock valued at $2,206,042,000 after acquiring an additional 2,391,434 shares during the last quarter. Institutional investors own 76.26% of the company’s stock.

About KKR & Co. Inc.

KKR & Co, Inc operates as an investment firm. It offers alternative asset management as well as capital markets and insurance solutions. The firm’s business segments include Asset Management and Insurance Business. The Asset Management segment engages in providing private equity, real assets, credit and liquid strategies, capital markets, and principal activities.